Filter News
Area of Research
News Topics
- (-) Advanced Reactors (2)
- (-) Biomedical (1)
- (-) Computer Science (3)
- (-) Machine Learning (2)
- (-) Transportation (1)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (4)
- Bioenergy (1)
- Cybersecurity (3)
- Fusion (1)
- High-Performance Computing (1)
- Isotopes (1)
- National Security (2)
- Neutron Science (1)
- Nuclear Energy (4)
- Partnerships (3)
- Physics (1)
- Security (2)
- Sustainable Energy (1)
Media Contacts
As vehicles gain technological capabilities, car manufacturers are using an increasing number of computers and sensors to improve situational awareness and enhance the driving experience.
The Department of Energy’s Oak Ridge National Laboratory announced the establishment of the Center for AI Security Research, or CAISER, to address threats already present as governments and industries around the world adopt artificial intelligence and take advantage of the benefits it promises in data processing, operational efficiencies and decision-making.
U2opia Technology, a consortium of technology and administrative executives with extensive experience in both industry and defense, has exclusively licensed two technologies from ORNL that offer a new method for advanced cybersecurity monitoring in real time.
A partnership of ORNL, the Tennessee Department of Economic and Community Development, the Community Reuse Organization of East Tennessee and TVA that aims to attract nuclear energy-related firms to Oak Ridge has been recognized with a state and local economic development award from the Federal Laboratory Consortium.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.